English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90074/105197 (86%)
Visitors : 7166567      Online Users : 46
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/25422


    Title: Role of HIF-1α-activated Epac1 on HSC-mediated neuroplasticity in stroke model.
    Authors: Li, Chen-Huan;Lin, Chen-Huan;Lee, Hsu-Tung;Lee, Hsu-Tung;李信達;Lee, Shin-Da;Lee, Wei;Lee, Wei;Che, Chin-Wen;Cho, Chin-Wen Chental;Shinn-Zong, L;Lin, Shinn-Zong;Hsiao-Jung, W;Wang, Hsiao-Jung;Oka, Hideyuki;Okano, Hideyuki;Hsu, Chung-Y;Hsu, Chung-Y;Woei-Cherng;Shyu, Woei-Cherng
    Contributors: 健康產業管理學系
    Keywords: CD34-immunosorted human umbilical cord blood hematopoietic stem cells;Cerebral ischemia;Epac1;Hypoxia preconditioning (HP);Immunoselection of CD34;exchange protein activated by cAMP;hUCB;hUCB(34);human umbilical cord blood
    Date: 2013-05
    Issue Date: 2013-07-11 14:24:35 (UTC+8)
    Abstract: Exchange protein activated by cAMP-1 (Epac1) plays an important role in cell proliferation, cell survival and neuronal signaling, and activation of Epac1 in endothelial progenitor cells increases their homing to ischemic muscles and promotes neovascularization in a model of hind limb ischemia. Moreover, upregulation of Epac1 occurs during organ development and in diseases such as myocardial hypertrophy, diabetes, and Alzheimer's disease. We report here that hypoxia upregulated Epac1 through HIF-1α induction in the CD34-immunosorted human umbilical cord blood hematopoietic stem cells (hUCB(34)). Importantly, implantation of hUCB(34) subjected to hypoxia-preconditioning (HP-hUCB(34)) improved stroke outcome, more than did implantation of untreated hUCB(34), in rodents subjected to cerebral ischemia, and this required Epac1-to-matrix metalloprotease (MMP) signaling. This improved therapeutic efficacy correlated with better engraftment and differentiation of these cells in the ischemic host brain. In addition, more than did implantation of untreated HP-hUCB(34), implantation of HP-hUCB(34) improved cerebral blood flow into the ischemic brain via induction of angiogenesis, facilitated proliferation/recruitment of endogenous neural progenitor cells in the ischemic brain, and promoted neurite outgrowth following cerebral ischemia. Consistent with our proposed role of Epac1-to-MMP signaling in hypoxia-preconditioning, the above mentioned effects of implanting HP-hUCB(34) could be abolished by pharmacological inhibition and genetic disruption/deletion of Epac1 or MMPs. We have discovered a HIF-1α-to-Epac1-to-MMP signaling pathway that is required for the improved therapeutic efficacy resulting from hypoxia preconditioning of hUCB(34) in vitro prior to their implantation into the host brain in vivo.
    Relation: NEUROBIOLOGY OF DISEASE,58:76-91.
    Appears in Collections:[健康產業管理學系] 期刊論文

    Files in This Item:

    File SizeFormat
    index.html0KbHTML150View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback